Intravenous use of intranasal naloxone: A case of overdose reversal.
Substance abuse · 2016-12-07 · Case report
Abstract
BACKGROUND: Opioid overdose is a growing concern in the United States and internationally. Prehospital or pre-medical personnel (layperson) administration of naloxone, an opioid antagonist, to reverse overdose, is an expanding mode of harm reduction. Recently, community clinics, methadone clinics, needle exchanges, some pharmacies, and other health care facilities have made naloxone available to the community. CASE: This case describes heroin overdose reversal of a 28-year-old male who had been using about a gram of heroin intravenously for 3 years but recently reduced frequency of use in an attempt to stop. He was seen initially 1 week prior to a buprenorphine induction in our clinic. After the initial intake, he used intravenous heroin, a larger amount than over the past several weeks in anticipation of abstinence, lost consciousness, and was difficult to arouse. A friend with him noted the patient's respirations to become shallow and administered naloxone nasal spray that the patient had obtained from a needle exchange, but did so intravenously by attaching an unused drug needle to the syringe barrel in place of the nasal atomizer. The patient's overdose was reversed and he recovered. DISCUSSION: This is the first known published case of a community-distributed naloxone nasal spray being used intravenously by a layperson (bystander). The case emphasizes the efficacy of naloxone in overdose reversal and also the need for education or instructions on naloxone use by others (not just the user). Finally, it highlights the risk of overdose in those entering treatment, seeking intoxication one last time.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Antidotes · Bystanders · Heroin · Intranasal administration · Naloxone · Poisoning & substance use
Related articles
- The Effect of Overdose Education and Naloxone Distribution: An Umbrella Review of Systematic Reviews. (Am J Public Health, 2021)
- Trends and characteristics during 17 years of naloxone distribution and administration through an overdose prevention program in Pittsburgh, Pennsylvania. (PLoS One, 2025)
- Do heroin overdose patients require observation after receiving naloxone? (Clin Toxicol (Phila), 2017)
- Emergency Department-Administered Extended-Release Buprenorphine After Fentanyl Overdose Reversed by Emergency Medical Services With Naloxone. (J Emerg Med, 2026)
- High-dose naloxone formulations are not as essential as we thought. (Harm Reduct J, 2024)
- Outcomes of law enforcement officer administered naloxone. (Am J Emerg Med, 2022)